172 related articles for article (PubMed ID: 27404978)
21. Infections Due to Carbapenem-Resistant Bacteria in Patients With Hematologic Malignancies.
Lalaoui R; Javelle E; Bakour S; Ubeda C; Rolain JM
Front Microbiol; 2020; 11():1422. PubMed ID: 32765433
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients.
Castón JJ; Lacort-Peralta I; Martín-Dávila P; Loeches B; Tabares S; Temkin L; Torre-Cisneros J; Paño-Pardo JR
Int J Infect Dis; 2017 Jun; 59():118-123. PubMed ID: 28392315
[TBL] [Abstract][Full Text] [Related]
23. Carbapenem-Resistant
Alexander EL; Loutit J; Tumbarello M; Wunderink R; Felton T; Daikos G; Fusaro K; White D; Zhang S; Dudley MN
Open Forum Infect Dis; 2017; 4(2):ofx063. PubMed ID: 28584849
[TBL] [Abstract][Full Text] [Related]
24. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho de Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Clin Infect Dis; 2017 Nov; 65(11):1819-1828. PubMed ID: 29020364
[TBL] [Abstract][Full Text] [Related]
26. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.
Liu J; Wang H; Huang Z; Tao X; Li J; Hu Y; Dou Q; Zou M
J Infect Dev Ctries; 2019 May; 13(5):357-364. PubMed ID: 32053504
[TBL] [Abstract][Full Text] [Related]
28. Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies.
Scheich S; Weber S; Reinheimer C; Wichelhaus TA; Hogardt M; Kempf VAJ; Kessel J; Serve H; Steffen B
Ann Hematol; 2018 Nov; 97(11):2225-2234. PubMed ID: 29974230
[TBL] [Abstract][Full Text] [Related]
29. Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant
Zhang P; Wang J; Hu H; Zhang S; Wei J; Yang Q; Qu T
Infect Drug Resist; 2020; 13():3233-3242. PubMed ID: 33061470
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies.
Mert D; Ceken S; Iskender G; Iskender D; Merdin A; Duygu F; Ertek M; Altuntas F
J Infect Dev Ctries; 2019 Aug; 13(8):727-735. PubMed ID: 32069257
[TBL] [Abstract][Full Text] [Related]
31. Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences.
Criscuolo M; Trecarichi EM
Antibiotics (Basel); 2020 Feb; 9(2):. PubMed ID: 32028615
[TBL] [Abstract][Full Text] [Related]
32. Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology.
Wang X; Zhang L; Sun A; Yang X; Sang W; Jiang Y; Cheng J; Wang J; Zhou M; Chen B; Ouyang J
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1073-1081. PubMed ID: 28101785
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
[TBL] [Abstract][Full Text] [Related]
34. Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy.
Ballo O; Tarazzit I; Stratmann J; Reinheimer C; Hogardt M; Wichelhaus TA; Kempf V; Serve H; Finkelmeier F; Brandts C
PLoS One; 2019; 14(1):e0210991. PubMed ID: 30673776
[TBL] [Abstract][Full Text] [Related]
35. Gut Colonization with Carbapenem-resistant Enterobacteriaceae Adversely Impacts the Outcome in Patients with Hematological Malignancies: Results of A Prospective Surveillance Study.
Jaiswal SR; Gupta S; Kumar RS; Sherawat A; Rajoreya A; Dash SK; Bhagwati G; Chakrabarti S
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018025. PubMed ID: 29755703
[TBL] [Abstract][Full Text] [Related]
36. Carbapenem-resistant Enterobacteriaceae in hematological patients: Outcome of patients with Carbapenem-resistant Enterobacteriaceae infection and risk factors for progression to infection after rectal colonization.
Zhang L; Zhai W; Lin Q; Zhu X; Xiao Z; Yang R; Zheng Y; Zhang F; Li S; Wang C; Feng S; Han M; Wang J
Int J Antimicrob Agents; 2019 Oct; 54(4):527-529. PubMed ID: 31279151
[No Abstract] [Full Text] [Related]
37. Management of carbapenem-resistant Enterobacteriaceae infections.
Durante-Mangoni E; Andini R; Zampino R
Clin Microbiol Infect; 2019 Aug; 25(8):943-950. PubMed ID: 31004767
[TBL] [Abstract][Full Text] [Related]
38. The rapid spread of carbapenem-resistant Enterobacteriaceae.
Potter RF; D'Souza AW; Dantas G
Drug Resist Updat; 2016 Nov; 29():30-46. PubMed ID: 27912842
[TBL] [Abstract][Full Text] [Related]
39. A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.
van Loon K; Voor In 't Holt AF; Vos MC
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038269
[TBL] [Abstract][Full Text] [Related]
40. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Gudiol C; Albasanz-Puig A; Laporte-Amargós J; Pallarès N; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Paz Morales H; Brunel AS; García E; Isler B; Kern WV; Morales I; Maestro-de la Calle G; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J;
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
